HARRIGAN EDMUND 4

What Happened Edmund Harrigan, a director of Incyte Corp (INCY), received awards of restricted stock units on June 8, 2026. The filing reports 1,642 RSUs and 6,111 derivative RSUs granted at $0.00 per share (total cash cost $0). The RSUs may be settled one-for-one for common stock and vest in full on the first anniversary of the grant (or earlier at the next annual stockholder meeting or upon a change of control) per the filing.

Key Details

• Transaction date: 2026-06-08; Form 4 filed 2026-06-10 (timely filing).
• Grant type: Award/Grant (code A).
• Amounts: 1,642 shares @ $0.00 (acquired); 6,111 derivative shares @ $0.00 (acquired) — total 7,753 RSUs.
• Price/value: $0 per RSU; no cash paid on grant.
• Vesting: Vests in full on first anniversary or earlier at next annual meeting or upon change of control (Footnote F1).
• Shares owned after transaction: Not specified in the filing.
• Notable footnotes: F2 states the 1,642 includes previously reported RSUs that have not vested; F3 describes option vesting rules but no option exercise appears in this report.

Context These awards are standard equity compensation for a director and are different from an open-market purchase or sale—RSUs are typically intended as long-term pay and only convert to shares upon vesting. Because the grants were issued at $0, they do not represent a cash purchase; they are not an immediate liquidity event (no immediate sale reported).